Open AccessA real-world analysis of relapse rate and efficacy of a restricted monthly dose of omalizumab in recalcitrant chronic spontaneous urticaria in India
Author(s) -
Kabir Sardana,
Niharika Dixit,
Pooja Arora
Publication year - 2020
Publication title -
indian dermatology online journal
Language(s) - English
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/idoj.idoj_499_19
Subject(s) - omalizumab , medicine , chronic urticaria , dermatology , immunology , immunoglobulin e , antibody